INT231163

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.06
First Reported 2008
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 7
Total Number 7
Disease Relevance 3.41
Pain Relevance 0.50

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell differentiation (Peg10) nucleus (Peg10) DNA binding (Peg10)
cytoplasm (Peg10)
Anatomy Link Frequency
blood 1
Peg10 (Mus musculus)
Pain Link Frequency Relevance Heat
Kinase C 1 92.88 High High
anesthesia 7 79.36 Quite High
cytokine 37 78.80 Quite High
Inflammation 93 78.40 Quite High
ketamine 6 68.76 Quite High
Inflammatory response 6 61.84 Quite High
Potency 18 21.12 Low Low
imagery 14 5.00 Very Low Very Low Very Low
alcohol 13 5.00 Very Low Very Low Very Low
dexamethasone 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Apoptosis 76 100.00 Very High Very High Very High
Stress 9 96.00 Very High Very High Very High
Diabetes Mellitus 92 93.12 High High
Injury 153 88.28 High High
INFLAMMATION 101 78.40 Quite High
Necrosis 6 66.96 Quite High
Obesity 5 58.40 Quite High
Muscular Dystrophy 90 33.92 Quite Low
Wound Healing 12 5.00 Very Low Very Low Very Low
Death 8 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
g total) complexed with the NG-PEI2K(PEG550)10 copolymer.
PEG550 Binding (complexed) of
1) Confidence 0.06 Published 2008 Journal BMC Biotechnol Section Body Doc Link PMC2362111 Disease Relevance 0 Pain Relevance 0.10
Specifically, 10 consecutive injections of the NG-PEI2K(PEG550)10 copolymer complexed with 5 ?
PEG550 Binding (complexed) of
2) Confidence 0.04 Published 2008 Journal BMC Biotechnol Section Body Doc Link PMC2362111 Disease Relevance 0 Pain Relevance 0
g of ESO complexed with either PEI2K(PEG550)10, NG-PEI2K(PEG550)10, or CG-PEI2K(PEG5K)10 copolymers and were analyzed for dystrophin expression at one week after the third injection.
PEG550 Binding (complexed) of
3) Confidence 0.04 Published 2008 Journal BMC Biotechnol Section Body Doc Link PMC2362111 Disease Relevance 0.07 Pain Relevance 0
g total) complexed with the CG-PEI2K(PEG5K)10 copolymer.
PEG5K Binding (complexed) of
4) Confidence 0.04 Published 2008 Journal BMC Biotechnol Section Body Doc Link PMC2362111 Disease Relevance 0 Pain Relevance 0.11
g of ESO complexed with either PEI2K(PEG550)10, NG-PEI2K(PEG550)10, or CG-PEI2K(PEG5K)10 copolymers and were analyzed for dystrophin expression at one week after the third injection.
PEG5K Binding (complexed) of
5) Confidence 0.04 Published 2008 Journal BMC Biotechnol Section Body Doc Link PMC2362111 Disease Relevance 0.07 Pain Relevance 0
g of ESO complexed with either PEI2K(PEG550)10, NG-PEI2K(PEG550)10, or CG-PEI2K(PEG5K)10 copolymers and were analyzed for dystrophin expression at one week after the third injection.
PEG550 Binding (complexed) of
6) Confidence 0.04 Published 2008 Journal BMC Biotechnol Section Body Doc Link PMC2362111 Disease Relevance 0.06 Pain Relevance 0
In support of glycation being involved in accelerating apoptosis of neutrophils in the peripheral blood of patients with T2DM a tight association between the rates of apoptosis with elevated HbA1c has been reported [35].
HbA1c Binding (association) of in blood associated with apoptosis
7) Confidence 0.01 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2832020 Disease Relevance 3.22 Pain Relevance 0.29

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox